Earnings History Data for Nektar Therapeutics (NKTR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Nektar Therapeutics

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain. In the area of pain, Nektar has a worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation. The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid. Also in the area of pain, NKTR-181, the company's wholly-owned novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies. Nektar Therapeutics is headquartered in San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2024 AH NKTR Nektar Therapeutics 257.71 -0.18 -0.22 -0.19 Nektar Therapeutics GAAP EPS of -$0.18 beats by $0.03, revenue of $24.12M beats by $5.84M
[11/7/2024 4:23 PM]		 1.40 0.03 
(2.18%)		 1.38 0.01 
(0.73%)		 0.41 - 1.93 1,439,418 2,030,000 15,119
08-08-2024 AH NKTR Nektar Therapeutics 214.84 -0.25 -0.21 -0.27 Nektar Therapeutics Non-GAAP EPS of -$0.19, revenue of $23.49M
[8/8/2024 5:50 PM]		 1.11 -0.09 
(-7.85%)		 1.19 -0.02 
(-1.65%)		 0.41 - 1.93 1,011,906 1,010,000 312
09-05-2024 AH NKTR Nektar Therapeutics 275.43 -0.18 -0.21 -0.25 Nektar Therapeutics GAAP EPS of -$0.19, revenue of $21.6M
[5/9/2024 4:22 PM]		 1.75 0.15 
(9.38%)		 1.62 0.02 
(1.32%)		 0.41 - 1.87 2,238,669 1,400,000 8,543
04-03-2024 AH NKTR Nektar Therapeutics 135.00 -0.22 -0.20 0.00 Nektar Therapeutics GAAP EPS of -$0.22 misses by $0.01, revenue of $23.89M beats by $2.52M
[3/4/2024 4:17 PM]		 0.8803 -0.02 
(-2.19%)		 0.89 -0.01 
(-1.12%)		 0.41 - 1.59 5,143,570 3,560,000 80,498
07-11-2023 AH NKTR Nektar Therapeutics 104.57 -0.19 -0.18 -0.24 Nektar Therapeutics Non-GAAP EPS of -$0.19 misses by $0.03, revenue of $24.1M beats by $2.79M
[11/7/2023 4:19 PM]		 0.5059 -0.04 
(-7.68%)		 0.52 -0.03 
(-6.02%)		 0.44 - 4.36 1,146,183 2,200,000 14,080
08-08-2023 AH NKTR Nektar Therapeutics 100.79 -0.27 -0.30 -0.85 Nektar Therapeutics GAAP EPS of -$0.27 beats by $0.01, revenue of $20.5M misses by $1.33M
[8/8/2023 5:00 PM]		 0.9090 -0.09 
(-9.10%)		 0.94 -0.06 
(-6.22%)		 0.51 - 5.18 15,886,598 22,150,000 568,417
09-05-2023 AH 4:15 PM ET
(May 9)		 NKTR Nektar Therapeutics 154.91 -0.25 -0.25 -0.49 0.7449 -0.02 
(-3.10%)		 0.79 0.02 
(2.12%)		 0.60 - 5.18 3,737,293 2,060,000 4,237
03-11-2022 AH 4:15 PM ET
(Nov 3)		 NKTR Nektar Therapeutics 714.01 -0.24 -0.47 -0.70 Nektar Therapeutics GAAP EPS of -$0.31 beats by $0.15, revenue of $23.63M beats by $1.02M
[11/3/2022 4:22 PM]		 3.77 0.21 
(5.76%)		 3.56 0.0 
(0.00%)		 2.96 - 17.79 937,089 1,090,000 40,314
04-08-2022 AH 4:15 PM ET
(Aug 4)		 NKTR Nektar Therapeutics 685.49 -0.85 -1.01 -0.69 Nektar Therapeutics GAAP EPS of -$0.85 beats by $0.15, revenue of $21.6M misses by $1.15M
[8/4/2022 4:33 PM]		 4.88 0.46 
(10.41%)		 4.88 0.0 
(0.00%)		 3.02 - 19.37 2,381,430 2,000,000 19,121
28-02-2022 AH 4:15 PM ET
(Feb 28)		 NKTR Nektar Therapeutics 1,880 -0.79 -0.81 -0.65 10.95 0.71 
(6.93%)		 10.55 0.31 
(3.03%)		 9.31 - 24.50 1,816,348 1,720,000 3,912
04-11-2021 AH 4:15 PM ET
(Nov 4)		 NKTR Nektar Therapeutics 2,980 -0.70 -0.80 -0.61 Nektar Therapeutics EPS beats by $0.10, misses on revenue
[11/4/2021 4:26 PM]		 13.44 -3.21 
(-19.31%)		 14.50 -2.15 
(-12.91%)		 12.35 - 26.75 5,095,591 1,020,000 73,315
05-08-2021 AH 4:15 PM ET
(Aug 5)		 NKTR Nektar Therapeutics 2,880 -0.69 -0.72 -0.45 Nektar Therapeutics EPS beats by $0.04, beats on revenue
[8/5/2021 4:29 PM]		 15.74 -0.13 
(-0.80%)		 15.87 0.0 
(0.00%)		 15.37 - 26.75 708,008 640,000 14,966
06-05-2021 AH 4:15 PM ET
(May 6)		 NKTR Nektar Therapeutics 3,430 -0.68 -0.74 -0.53 Nektar Therapeutics EPS beats by $0.07, misses on revenue
[5/6/2021 4:16 PM]		 20.10 1.58 
(8.53%)		 20.10 0.0 
(0.00%)		 15.39 - 26.75 2,859,113 800,000 43,920
25-02-2021 AH 4:15 PM ET
(Feb 25)		 NKTR Nektar Therapeutics 4,040 -0.65 -0.72 -0.64 Nektar Therapeutics EPS beats by $0.03, misses on revenue
[2/25/2021 4:22 PM]		 22.80 0.36 
(1.60%)		 22.14 -0.30 
(-1.34%)		 13.63 - 26.75 1,228,767 1,596,589 491
05-11-2020 AH 4:15 PM ET
(Nov 5)		 NKTR Nektar Therapeutics 2,820 -0.61 -0.80 -0.56 Nektar Therapeutics EPS beats by $0.16, beats on revenue
[11/5/2020 4:25 PM]		 17.41 0.52 
(3.08%)		 17.00 0.11 
(0.65%)		 13.63 - 28.60 1,444,410 1,241,188 1,166
06-08-2020 AH 4:15 PM ET
(Aug 6)		 NKTR Nektar Therapeutics 3,930 -0.45 -0.69 -0.63 Nektar Therapeutics EPS beats by $0.23, beats on revenue
[8/6/2020 4:19 PM]		 22.50 0.99 
(4.60%)		 22.59 1.08 
(5.02%)		 13.63 - 29.99 585,187 801,153 1,557